Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
New purpose-built AI model targets faster R&D cycles and deeper scientific insights across life sciences
Zero-observation outcomes strengthen global credibility and accelerate CDMO ambitions
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
Through the partnership, she plans to share her experience—from consultation through recovery—across her social media platforms
The collaboration will embed OpenAI’s advanced AI systems across Novo Nordisk’s global operations
CDSCO-approved therapy enters India’s fast-growing post-patent GLP-1 market with fully integrated API, formulation and pen manufacturing
Subscribe To Our Newsletter & Stay Updated
